Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Strataca Systems is a private clinical-stage medical device company focused on technologies to sustain or enhance kidney function. The company has operated under the Strataca Systems name and more recently as Roivios, with 3ive Labs serving as its R&D subsidiary. Its lead product is the JuxtaFlow Renal Assist Device, a first-of-its-kind negative-pressure renal assist catheter system intended initially for patients with renal insufficiency undergoing cardiac surgery with cardiopulmonary bypass. The company has also studied JuxtaFlow in fluid-overloaded heart failure patients and historically described an additional device program aimed at slowing chronic kidney disease progression. Strataca/Roivios appears to be an active, venture-backed private medtech company with operations tied to Georgia in the United States and corporate presence in Malta/Bahamas in various company records.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Strataca Systems.